Schonfeld Strategic Advisors LLC Atai Life Sciences N.V. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$2.38 - $3.55 $918,918 - $1.37 Million
386,100 Added 448.95%
472,100 $1.26 Million
Q3 2022

Nov 14, 2022
BUY
$3.14 - $4.87 $19,468 - $30,194
6,200 Added 7.77%
86,000 $284,000
Q2 2022

Aug 15, 2022
BUY
$3.03 - $5.32 $141,804 - $248,976
46,800 Added 141.82%
79,800 $290,000
Q1 2022

May 16, 2022
BUY
$4.66 - $7.66 $153,780 - $252,780
33,000 New
33,000 $168,000

Others Institutions Holding ATAI

# of Institutions
87
Shares Held
12.4M
Call Options Held
77.8K
Put Options Held
50.3K
View Full List

About ATAI Life Sciences N.V.

ATAI Quotes by TradingView
  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email